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Direct Demonstration in Cultured Cells 
EDWARD O'KEEFE, M.D., TERESA BATTIN, AND RICHARD PAYNE, JR. 
Department of Dermatology, University of North Carolina, Chapel Hill, North Carolina, U.S.A. 
The interaction of [1251] labeled murine epidermal 
growth factor (EGF) with cultured human keratinocytes 
has been studied. Epidermal cells from neonatal fore-
skins were propagated to confluence in 24-well culture 
trays and incubated with [1 251] EGF for binding assays. 
Association reached equilibrium within 2-4 hr at 4 o and 
slightly earlier at 37°. EGF bound at 37° dissociates very 
slowly from cells, since it can be shown to enter cells and 
is degraded to trichloracetic-acid-soluble material. Cells 
exposed to chloroquine, an inhibitor of lysosomal en-
zymes, fail to degrade internalized P251] EGF. Scatchard 
plots of the binding data yield a dissociation constant of 
1 x 10-9 M and show that epidermal cells bind approxi-
mately 3-4 X 104 molecules ofEGF. Cells exposed to EGF 
alter their ability to bind EGF by decreasing the number 
of binding sites in a time- and concentration-dependent 
manner. DiffP-rentiation of epidermal cells in culture 
poses a problem in assessment of binding of EGF and 
possibly of other biologically active ligands, since cells 
lose the ability to bind EGF as they differentiate. These 
findings indicate that isolated epidermal cells possess a 
functional receptor for EGF which binds and responds 
to EGF in a manner similar to that described for other 
cells. 
Epidermal growth factor, a purified 6045 dalton polypeptide 
stored in the mouse submaxillary gland, has been demonstrated 
in human tissues and serum [1]. This very stable protein has 
striking mitogenic potency in fibroblasts [2) and a unique target 
specificity as measured in binding studies to cells and mem-
branes from various organs [3]. In addition to pleiotypic effects 
culminating in cell division both murine and human epidermal 
growth factor, also called urogastrone, abolish gastric acid se-
cretion after parenteral administration [ 4). 
The role of epidermal growth factor (EGF) in growth and 
differentiation of epidermis is unclear. In chick epidermis in 
organ culture, EGF produces epithelial proliferation [5]. In 
newborn mice differentiation of eyelids with epithelial prolif-
eration and subsequent fission of the lid into upper and lower 
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halves with cornification of the adjacent sw-faces is enhanced 
by injections of EGF [6). In epidermal cultw-es using mouse 
fibroblast feeder layers, EGF may produce increased generative 
capacity before senescence in culture [7], increased colony 
forming efficiency [7], and synergistic growth response with 
agents elevating cyclic AMP concentrations [8). In human 
epidermal cell cultures without a feeder layer, no effect of EGF 
has been demonstrated by Ham's laboratory [9). Liu and Kar-
asek [10) demonstrated an effect of EGF on growth of isolated 
keratinocytes. Growth potentiation was more marked on sub-
culture and in the presence of hydrocortisone. 
EGF binding and biological responsiveness have been exten-
sively characterized in fibroblasts. In isolated epithelium in the 
absence of fibroblasts only the studies of Cohen [5] and Liu and 
Karasek [10] document the action ofEGF. EGF binding activity 
has been described in cultw-ed epidermoid carcinoma [11], 
membranes from corneal epithelium [3), and more recently in 
cultured mouse keratinocytes [12]. We have sought to address 
the role of 'EGF in human keratinocytes directly in prin1ary 
cultures by studying the binding of [ 125I] labeled EGF. 
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MATERIALS AND METHODS 
Cell Culture 
Epithelial cells were cultured from human newborn foreskins by a 
modification of the method of Rheinwald and Green [13]. Briefly, fat 
was removed by scalpel and the skin incubated for 16 hr at 4 ° in Hanks' 
buffered salt solution (HBSS) and 30 mM Hepes containing 75 units 
penicillin per ml, 75 ug streptomycin per ml, and 0.1% trypsin on a filter 
paper according to Hawley-Nelson et al [14]. The epidermis was peeled 
off and minced with forceps in a Petri dish in medium without trypsin 
to produce clumps and single cells and plated as desired in Dulbecco's 
modification of Eagle's minimal essential medium with 2 mM glu tamine 
(DME) containing 5% fetal bovine serum (FBS) and supplements 
described below. . 
Swiss 3T3 cells obtained from the American Type Cultw-e Collection 
and grown in DME with antibiotics and 10% FBS were exposed to 4 ug 
mitomycin C per ml for 2 hr at 37°, trysinized and plated with the 
epithelial cells at 2 X 104 cells/cm2 in DME containing 5% FBS and 
antibiotics at 37° in 8% C02. Swiss 3T3 cells were removed weekly with 
0.02% EDTA in calcium- and magnesium-free phosphate buffered saline 
and replenished until the keratinocytes were 80% confluent, after which 
3T3 cells were removed, since the epithelial cells were able to grow 
without the feeder layer at this point. Keratinocytes could then be 
trypsinized and passaged without a feeder layer if plated at 0.5-1.0 X 
105cells/cm2. Cells were subcultured in DME with 2.5% FBS. CultUJ"e 
media contained cholera toxin (10 ng/ ml) , epidermal growth factor (10 
ng/ ml), insulin (5 ug/ml), hydrocortisone (0.4 ug/ml) and transferrin 
(5 ug/ml) except prior to binding studies, for which EGF was removed 
for at least 72 hr. EGF was usually not added when cells were subcul-
tured for binding studies. Unless specified otherwise, cells were subcul-
tured in the absence of 3T3 cells. 
Binding Experiments 
EGF was purified according to Savage and Cohen [15] from adult 
male mice injected subcutaneously 10 days before sacrifice with l mg 
of testosterone enanthate and was iodinated using Chlmamine T as 
described [3] to a specific activity of0.7-1.9 x lOG cpm/pmol. Epidermal 
cells in monolayers in 24-well flat-bottom tissue cultuTe trays (Linbro) 
were grown for 3-6 days in medium lacking added EGF and exposed to 
[ 1" 51] EGF in triplicate samples as in individual figure legends. In the 
standard binding assay [3], cells were washed with Hanks' buffered salt 
solution containing 20 mM HEPES and 0.1% bovine serum albumin 2 
times and then incubated on ice for 30 min. Native EGF was added to 
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one well of ~ach experimental point to determine nonspecific binding 
at a fina l concentration of 10- 6 M and [ 1251] EGF added for 2 hr or more 
to all wells in 0.4 ml volume. To terminate the incubation cells were 
washed 4 times with phosphate buffered saline (PBS) containing 0.1% 
albumin and solubilized in 1% SDS in 0.1 M NaOH and radioactivity 
counted in a gamma scintillation counter at 55% efficiency. Binding 
assays were carried out at 4° if internalization of bound hormone was 
to be prevented and at 37° if this was de ired. Data were analyzed 
according to Scatchard [16] and best fitting lines determined by linear 
regression. Only specific binding is shown. Nonspecific binding was 
usually less than 10% of total. 
Reagents and Chemicals 
Tissue cultme media were obtained from Flow Laboratories, and 
trypsin and fetal bovine serum from Gibco. Chloroquine, insulin, hy-
drocortisone were from Sigma, and cholera toxin was from SchwaJ"Z-
Mann. Linbro plastic ware was from Flow Laboratories. ( 1251] Nal 
(carrier-free) was from Amersham. 
RESULTS 
Cultures showed typical epithelial morphology and were de-
void of fibroblasts by morphological criteria and by immunoflu-
orescent staining using antifibronectin antibody and flum·es-
cein-conjugated goat anti-rabbit immunoglobulin. Mouse and 
human fibroblasts show brilliant lineru· networks with this 
reagent, while epidermal cells do not stain. Polyacrylamide gels 
of cells solubilized in SDS and stained with Coomassie blue 
show heavy bands in the range of 40-60 kilodaltons typical of 
keratin (data not shown). 
Binding of t 25l} EGF to Cultured Keratinocytes 
The association of C25I] EGF and cultured keratinocytes is a 
time- and temperatw·e-dependent event. Although at 37° as-
sociation is more rapid than at 4 °, it is complicated by secondru·y 
processes such as internalization and degradation of the bound 
peptide (see below and references 17, 18). To study the binding 
reaction alone, association was studied at 4° and was found to 
reach near equilibrium by 2-4 hr under the conditions described 
in Fig 1. Dissociation at this temperature was very slow (less 
than 10% in 60 min) but was also negligible at physiologic 
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FIG 1. Association of [1251] EGF and cu ltured epidermal cells. Once 
subcultmed epidermal cells (1.2 X 10'' cells per well) were grown to 
confluence in Linbro 24 well trays and fed with medium lacki11g EGF 
for 6 clays. Medium was then changed to 0.4 ml HBSS-0.1% albumin 
with 20 mM Hepes, cooled to 4°, and native EGF (10- 6 M) was added to 
every 4th well for 30 min. [ 1251] EGF (930,000 cpm, 1.3 x 10-" M final 
concentration) was added to all wells and the incubation continued at 
4 ° for vru·ious times, and 4 wells assayed for each tin1e point. All wells 
were washed 4 times with 2 ml cold phosphate buffered saline contain-
ing 0.1% albumin, solubilized with 1 ml 1% SDS in 0.1 M NaOH,-and 
counted in a gamma counter. 
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FIG 2. Binding of [ 1251] EGF to cul tured human epidermal cells. 
Epidermal cells were grown in 100-mm Petri dishes and subcultUl·ed at 
high density (1 x 105 cells/ 2 cm2 well) in 24 well trays without EGF. 
When cells were confluent, medium was replaced with HBSS-0.1% 
albumin containing 20 mM Hepes and the stru1dard binding a say 
performed using 3 wells per point at 4° using vru·ious concentrations of 
( 1251] EGF in a 3-lu· incubation. Insets show Scatchard plots of the 
binding data. A, Binding curve using higher specific activity [ 1251] EGF 
( 1.9 X 106 cpm/pmol) to examine the lower portion of the curve showing 
higher affinity binding sites. B, Binding curve showing satmation of 
binding (specific activity of [' 251] EGF, 1.1 x 10c; cpm/ pmol). Wells 
contained approximately 3 x 10" (A) or 5 x 105 (B) cells per well. 
temperatures, probably because of incorporation of bound pep-
tide into the cells. Attempts to study dissociation in membrane 
prepru·ations following subcellular fra~tionation were unsuc-
cessful because of the very low binding activity of such prepa-
rations. This low specific activity of binding is a consequence of 
the small number of receptors detected in these cells and 
perhaps also of proteases freed by disruption of cells. 
Under equilibrium conditions the binding of [' 25I] EGF to 
cultmed keratinocytes shows a complex binding curve with 
satmation of high affinity binding at about 2-3 X 10- 10 M as 
well as additional lower affinity binding of about 4-fold higher 
capacity (Fig 2a, b). The high affinity binding (Fig 2a) is best 
demonstrated with C25I] EGF labeled to a specific activity of 1 
Ci/umol or higher but is reproducible in both primary cultures 
and subcultured cells. The lower affinity binding shows satu-
ration of receptors with an affmity constant of 1 X 10- 9 M, 
comparable to that seen with fibroblasts [2,17,19]. A similar 
binding cw·ve is seen with longer incubations and is not caused 
by failure to reach equilibrium at lower concentrations. 
Internalization and Degradation of Bound EGF 
In an association experiment performed as in Fig 1 but at 
37°, saturation of binding occms more rapidly than at 4° (Fig 
3) as expected in a bimolecular reaction at higher temperature. 
If cells are washed 3 times at 10-min intervals at 37° and 
counted for retained radioactivity, dissociation of bound [ 1251] 
EGF can be measw·ed. As shown previously, labeled EGF 
bound to placenta membrane prepru·ations at physiological 
temperatures is rapidly dissociable and has a half-life of disso-
ciation of approximately 5 min [3]. Intact epidermal cells in 
cultme, however, show little loss of bound EGF (Fig 3) under 
conditions where 90% of the label would be lost from placenta 
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FIG 3. Effect of washing cells on [' 251] EGF bound by epidermal 
cells at 37°. The association experiment was performed as in Fig 1 but 
at 37°. In a parallel series of wells, following addition of [ 1201] EGF, 
cells were washed, incubated for two 10-min periods followed by wash-
ing at 37°, and then assayed for radioactivity. Only specifically bound 
radioactivity is shown. - 0 -,control wells - e -,washed wells. Washing 
removes less than 10% of specifically bound [1201] EGF at 37°. Specific 
activity of [ 1251] EGf is 1.1 x 106 cpm/pmol. 2.8 x 105 cells per well. 
membranes. ['251) EGF bound by intact cells is only partially 
removed by trypsin treatment of cells. Cells which have been 
exposed to [ 1251) EGF for 2 hr at 37° release only 31-33% of 
bound label during a 15-min exposure to trypsin (200 ug/ml), 
while 95% of radioactivity bound to membrane preparations 
can be released under dissociating conditions. 
If epidermal cells are allowed to bind [' 251) EGF and then 
washed at intervals for prolonged periods, the rate of loss of 
radioactivity during each interval can be assessed by counting 
the supernatant. The integrity of the released material can also 
be examined, since intact EGF is precipitated in cold 5% tri-
chloracetic acid (TCA). Figure 4 shows that bound radioactivity 
is lost from intact keratinocytes at 37" with a half-life of 
approximately 90 min. The material released is largely degraded 
EGF, which is no longer TCA-precipitable. These data are 
consistent with fmdings in fibroblasts [17,18] that EGF is inter-
nalized and degraded. 
The degradation, but not internalization, of EGF is known to 
be inhibited by chloroquine and several other amines [18]. If 
the binding, internalization, and degradation of [1251) EGF are 
a receptor-mediated process, chloroquine would be expected to 
decrease the release of EGF from intact cells. As shown in Fig 
5, cells incubated in 0.2 mM chloro.quine accumulate radioactiv-
ity at a faster rate than do control cells, and the association 
curve fails to saturate. After 7 hr, chloroquine-treated cells 
accumulate 2 times the radioactivity of control cells. 
Down Regulation 
Loss of surface receptors in response to EGF exposure has 
been demonstrated in fibroblasts [17) and is thought to require 
metabolic processes following binding; it is not accounted for 
solely by receptor occupancy. This "down regulation" was 
sought in human keratinocytes by exposing the cells to native 
EGF for various times, continuing the incubation at 37° to 
allow dissociation or internalization of bound EGF, and then 
measuring binding of [1251] EGF. To assuxe that native EGF 
added to cells to· induce down-regulation has been removed 
from the cell surface prior to binding experiments, the fate of 
[ 1251] EGF bound to cells at 37° was examined. As shown in Fig 
4, 60% of the cell-associated radioactivity has disappeared by 2 
hr. Furthermore, less than 5% of that remaining after 2 hr in 
the absence of EGF is accessible to trypsin (data not shown). 
Vol. 78, No. 6 
Therefore the loss of EGF binding demonstrated in down-
regulation experiments cannot be accredited to remaining sur-
face-bound EGF. In cells incubated for various times up to 6 hr 
with 50 ng/ml native EGF, washed, and then cooled to 4° for 
the standard binding assay, binding of EGF is 95% at 2 hr, 92% 
at 4 hr, and 90% at 6 hr in comparison with controls. As shown 
in Fig 6, however, greater than 50% loss of EGF binding is 
produced by these proceduxes in a 24-hr incubation. The loss is 
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FIG 4. Fate of [1251] EGF processed by epidermal cells. Epidermal 
cells (1.5 X 10" cells per well) were incubat.ed in triplicate with 3.2 X 105 
cpm of [ 1251] EGF (1.3 X 10- 9 M) for 2 hr at 37° and all wells were then 
washed 3 times with cold PBS-0.1% albumin. Every third well had 
previously received 10- •; M native EGF for 30 min prior to labeled EGF. 
At hourly intervals the supernatants were saved from 3 wells and all 
wells still containing cells were washed 3 times with PBS-0.1% albumin 
at 37°. The cells in the 3 wells from which supernatant was saved were 
solubilized and counted. Supernatants were made 0.5% in a lbumin, 
combined with an equal volume of cold 10% TCA at 4°, incubated 30 
min at 4 o, centrifuged, and the supernatants counted to determine 
TCA-soluble radioactivity. [ 1251] EGF is greater than 90% TCA precip-
itable. The experiment demonstrates the increasing percentage ofTCA 
solubility of radioactivity released by cells into the supernatant during 
sequential 1-hr periods following washings and shows the time course 
of degradation of cell-associa ted [' 2''1] EGF. ----0--, cell associated 
radioactivity; e radioactivity in supernatants; --6--, % 
TCA-soluble radioactivity. 
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FIG 5. Effect of chloroquine on [ 1251] EGF processing by epidermal 
cells. Cells (8 X 105 per well) were incubated in triplicate with 3.2 X 105 
cpm ( 1251] EGF (5 X 10- 10M) with or without 0.2 mM chloroquine for 
various times at 37° and washed 3 times with cold PBS-0.1% albumin, 
solubilized, and counted. One well of 3 received 10- 6 M native EGF 30 
min prior to labeled EGF to assess nonspecific binding. -0-, chloro-
quine treated, e control. 
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FIG 6. Time course of EGF-induced down-regulation of EGF recep-
tot·s. Subcultured cells (1.2 X 105 cells per well) were incubated with or 
without 30 ng/ ml native EGF for designated times, washed with PBS-
0 .1% albumin at 37°, washed again every 2 hr for 3 washes, and cooled 
to 4°. Every 4th well received 10- 6 M native EGF for 30 min to assess 
nonspecific binding and all wells were incubated with 5.2 X 105 cpm 
( 1251] EGF (1.1 X 106 cpm/pmol) for 2 hr, washed 4 times, solubilized, 
and counted. Error bars denote standard error of the mean. 
concentration dependent, with maximal down regulation occm-
ring in the range of 10-50 ng/ml ofEGF (Fig 7). Scatchard plots 
of the binding data show that decreased binding is associated 
with decreased receptor number (data now shown). 
Lo,<;s of EGF Binding in Association with Differentiation 
Since keratinocytes differentiate in culture to produce des-
quamated terminally differentiated cells, we determined 
whether these cells bound [ '2"1] EGF. If not, these cells, since 
they are present in the binding reaction, would influence ow· 
effort to determine the number of EGF receptors per celL 
Differentiated cells were examined in 3 ways. First, desqua-
mated cells when harvested, washed, and assessed for binding 
did not demonstrate any ability to bind [12"1) EGF, even in 
numbers that would have permitted demonstration ofless than 
500 receptOl's per cell. 
Second, assessment of binding was performed in 2 types of 
cultures with different extent of differentiation. Primary cul-
tures were plated in 24 well trays with 3T3 feeder layers and 
the 3T3 cells removed prior to confluence of the keratinocytes. 
The keratinocytes were permitted to stratify and differentiate, 
and EGF binding was measmed in the standru:d binding assay. 
These cultmes contained 1.1-1.7 X 106 cells per 2 cm2 well and 
showed 30-50% cross-linked envelopes [20] resistant to solubil-
ization by 1% SDS and 10 mM dithiothreitol (DTT). The second 
type of cultme was prepared by subcultming at high density in 
the absence of 3T3 cells keratinocytes from a nearly confluent 
100 mm dish. These cells have a relatively high plating effi-
ciency (10-30%) and form a monolayer with negligible stratifi-
cation. The final cell density is only 1-2 X 10" cells per 2 cm 2 
well, and crosslinked envelopes ru·e found in less than 3% of 
cells 3 to 6 days after plating when the binding assay is per-
formed. Binding experiments show that both types of cultmes 
bind equal amounts of C25I] EGF, consistent with the possibility 
that only about 10% of cells in the dense, more differentiated 
cultmes bind EGF (Table). 
Third, EGF binding was measured in cultured keratinocytes 
established directly from foreskins as they became progressively 
more differentiated. One set of cultures was maintained in 5% 
FBS and a second starved in 0.5% serum to increase differen-
tiation. In parallel with binding measmements, cells were tryp-
sinized and counted over a 6-day time course. The results 
indicate that EGF binding falls as cells become progressively 
differentiated (Fig 8) . Although the percentage of cells resistant 
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to solubilization with DTT and SDS did not differ in the two 
types of cultures, on day 4 (Fig 8) serum-starved cultures 
showed up to 30% of cells resistant to detergent alone, while 
serum-fed cultmes showed only 11%. Thus progressive differ-
entiation assessed by resistance to solubilization by detergent 
alone or by crosslinked envelope formation is associated with 
loss of binding of C25l] EGF. 
DISCUSSION 
The data presented here demonstrate by direct binding mea-
smements the presence of a functional EGF receptor in cultured 
human keratinocytes. Equilibrium binding experiments per-
formed under conditions in which internalization is inhibited 
show binding affinity in the range of physiological EGF concen-
trations (approximately w - IO M). The binding is saturable and 
inhibited by excess unlabeled EGF. Calculation of the number 
of binding sites for EGF is complicated by the fact that cells 
which differentiate lose the ability to bind EGF and thus lower 
the appru·ent binding of EGF per cell. Examination of binding 
in differentiated, desquamated cultured cells; in cultures con-
taining high and low proportions of differentiated cells (Table); 
and in ageing cultures showing advancing differentiation (Fig 
8) indicates that binding by differentiated cells can probably be 
ignored. Under the best conditions, in subcultmed cells which 
have not yet stratified, the cells show high affinity binding sites 
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FrG 7. Concentration dependence of EGF-induced down regulation 
ofEGF binding. Subcultw·ed cells (1.2 x 105 cells per well) were treated 
in triplicate with or without native EGF at vru·ious concentrations for 
16 hr at 37°, washed at hourly intervals for 4 washes, and incubated 
with 4.25 X 105 cpm [ 1251] EGF (1.1 X 106 cpm/ pmol) for 2 hr at 4o. 
Every third well received 10- 6 M native EGF for 30 min prior to labeled 
EGF to assess nonspecific binding, and each point was determined in 
triplicate. Cells were then washed 3 times with PBS-0.1% a lbumin, 
solubilized, and counted. 
Binding of {' 25!] EGF to epidermal cell cultures with differing 
degrees of differentiation 
Type of Cu lture Cell Number cpm bound per % Crossl inked enve-
well lopes 
Primru·y 1.1-1.7 X lOr. 6,140-9,800 31-52 
Subculture 1.1-1.9 X 105 7,170-10,510 0.1-3.0 
Cells were cultured as in Materials and Methods a nd studied in 
triplicate in the standru·d binding assay using 5.1 x 10'' cpm [' 251] EGF 
(7 X 105 cpm/ pmol) for 3 lu· at 4 °. Only specific binding is shown. Cells 
were trypsinized and counted both for cell number in a hemocytometer 
and for radioactivity. Envelopes were counted after treatment of the 
cell suspension with 1% SDS and 10 mM DTT for 5 min at 24°. 
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differentiate. Confluent cells were subjected to the standard binding 
assay in quadruplicate following feeding on day 0 with 5% (-0 -) or 0.5% 
(-e-) fetal bovine serum using C2"I] EGF of specific activity 0.7 X 10" 
cpm/pmol. Cells in every fourth well were trypsinized and both cells 
and supernatant were counted for radioactivity. Cells were counted for 
cell envelopes after solubilization in 1% SDS, 10 mM DTT [20]. This 
experiment showed similar results when repeated twice. Every fourth 
well was assayed for nonspecific binding by prior addition of w-•; M 
EGF 30 min before labeled EGF. Cell number was relatively constant 
at 0.9-1.2 X 10" cells per well. Percentage of envelopes resistant to 
detergent and reducing agent shown for 5% (-6-) and 0.5% (-•-) serum. 
(Ko = 3 X 10- 10M) for 8-20 X 10'1 molecules per cell and total 
binding including lower affinity sites (Kn = 1 X 10- 9 M) of 3-4 
X 104 molecules per cell. The significance of this relatively small 
component of higher affinity sites is unclear, but it m ay be 
pertinent that human EGF concentrations in serum are thought 
to be approximately 3 X 10- 10 M [1]. The overall affinity 
including all specific binding is similar to that described in 
humarrfibroblasts (Ko = 10- u M) which show 4 X 104 to 1 X 10" 
[2] receptors per cell. The number of EGF receptors in neonatal 
epidermal cells in culture can therefore be said to be equal to 
or less than that of cultured fibroblasts. 
In early studies of EGF it was found that [' 2"I] EGF injected 
into rats was most highly concen trated in the epidermis· and 
cornea [21] , suggesting high numbers of receptors in t hese 
epithelia. The presence of greater than 2 X 106 receptors per 
cell in th e epidermoid carcinoma cell line A-431 (ll] suggests 
that human skin epithelial cells might show higher numbers of 
receptors than fibroblasts. Some epithelia m ay indeed confirm 
this prediction; membranes from amnion show extremely high 
EGF binding [22] in comparison with other tissues. 
Specifically bound [' 2"1] EGF do.es not dissociate appreciably 
after binding at 37° (Fig 3) . Dissociation from membrane prep-
arations of placenta is rapid under these conditions [3]. Specif-
ically bound (' 2"I] EGF is incorporated into cells only at phys-
iologic temperatures and becomes inaccessible to trypsin. [ 12"IJ 
EGF incorporated into cells is converted to TCA-soluble radio-
activity in the absence of an inhibitor of lysosomal enzymes 
(Fig 4), but in its presence label accumulates to a greater extent 
than in control cells (Fig 5) . Fluid phase pinocytosis does not 
account for intracellular accumulation of radi'oactivity, since 
( 1251] bovine serum albumin is no t significantly incorporated 
(data not shown). These findings are consistent with internali-
zation and degradation ofEGF described in fibroblasts (17] and 
suggest that binding of EGF measured in these experiments is 
physiologically significant, or to true receptors. 
Since m embrane preparations do not degrade bound EGF 
[3], degradation probably does not occur at the cell surface but 
intracellularly. Loss of radioactivity at 37° is slow, with 50% loss 
at 90 min (Fig 4), and released radioactivity is largely degraded 
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EGF. [' 2"1] EGF which dissociates from membrane preparations 
is intact, and dissociation is rapid, with 50% loss by 5 min r3l 
Down regulation of surface receptors, a widely detected phe-
nomenon in response to hormones and growth factors, usually 
occurs within several hours of exposure to ligand. This ligand-
mediated loss of receptors is maximal within 3 hr in 3T 3 cells 
with EGF [23]. In the IM-9 cultured lymphocyte line, however, 
the response to insulin is concentration-dependent and requires 
longer incubations at physiologic concentrations of insulin 
[24]. In human keratinocytes the response is concentration- and 
time-dependent and also requires longer incubations. Only 
5-10% loss in binding is seen after 6 hr at 37°, but 40% loss is 
seen after 16 hr. Epidermal cells, like fibroblasts, may modify 
their responsiveness to growth factors and hormones by mod-
ulation of surface receptor number. Degradation of bound EGF 
occurs more rapidly than down regulation of receptors. The 
reason for this discrepancy is unknown. Disequilibrium between 
these processes could be accounted for by resynthesis or recy-
cling of receptors at unequal or varying rates. 
The loss of EGF binding by differentiating cells may be a 
reflection of cell death accompanying differentiation. Alterna-
tively, the possibility is raised that changes in EGF receptor 
activity, possibly triggered by changes in calcium metabolism 
[14] accompanying differentiation, are significant in initiating 
differentiation. It may be important in this regard that cells 
maintained in the presence of EGF are less likely to terminally 
differentiate [7,10] and can be maintained through more divi-
sion in culture [7]. 
We thank Drs. G. Lazru·us and K. Singer for assistance with epithelial 
cell culture. 
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Announcement 
A H awaiian Dermatology Seminar will be held in Maui, Hawaii, February 1-6, 1983. 
Thi? pos~graduate course is sponsored by the Northwestern University, Cleveland Clinic, and University 
of Califorma (San Francisco) Departments of D ermatology. SpeaKers include faculty ofthese departments 
and guest faculty. The presentations will emphasize diagnosis and treatment of common cutaneous 
disorders. There will be a postconvention meeting in Kaui from Februru·y 6-9, 1983. This will be in 
collaboration with the State of Hawaii Dermatological Society. For r egistrat ion information and prelim-
inary program, write: Depru·tment of Dermatology, Northwestern University Medical School 303 E. 
Chicago Ave, Chicago, IL 60611. ' 
